)
Established in 1997, Serosep was born from a belief in delivering superior diagnostic solutions. Initially, the company focused on distributing carefully selected diagnostic products for Clinical Microbiology, Histopathology, and Environmental Laboratories. This early endeavor laid the foundation for what would become a remarkable journey in the field of diagnostics.
As Serosep evolved, so did its commitment to staying at the forefront of diagnostic solutions. Continuous analysis of the best available options in the market became a continuous practice, resulting in an extensive wealth of market knowledge. This, coupled with years of experience in distributing to clinical laboratories, granted Serosep a profound understanding of the daily challenges faced by laboratory personnel.
The company's dedication to excellence and customer-centricity paved the way for the exploration of new and exciting opportunities. 27 years later Serosep stands as a thriving entity with 92 FTE in its Ireland operation, 16 FTE in its UK subsidiary and 6 in SA. Their unwavering investment in research and development facilities, combined with a resolute commitment to innovation and product advancement, positions Serosep at the forefront of the diagnostic solutions market.
Serosep's impact extends across the globe, with their product range reaching five continents and achieving remarkable sales in over 35 countries. In a notable milestone, 2021 saw Serosep honoured as the Medtech Company of the Year. This accolade is both a testament to Serosep’s achievements and an inspiration to strive for even greater heights in the future, solidifying Serosep's standing as an industry pacesetter.
Recent Media Coverage
https://www.limerickleader.ie/news/sponsored-content/826348/serosep-celebrating-25-years-of-diagnostic-excellence.html
https://www.limerickleader.ie/news/sponsored-content/1174628/serosep-creating-a-culture-of-trust.html
https://www.ilovelimerick.ie/serosep/
https://irishmedtechskillnet.ie/IBEC/Press/PressPublicationsdoclib3.nsf/wvSkillnetIMDANews/serosep-wins-irish-medtech-company-of-the-year-2021-02-12-2021!OpenDocument&Click=
Market Serve: UK, Africa, Europe, Rest of World, Middle East
Why work with us
Serosep exports to over 35 countries worldwide and has taken its products through FDA, CE-IVDR and MHRA regulatory approval to access its target clinical markets highlighting Serosep’s strong commitment to meeting high regulatory standards.
Serosep’s focus on the clinical invitro diagnostic (IVD) market specifically in infectious disease has seen the company build talented and diverse teams in R&D production, QC, regulatory, applications, technical support, sales & marketing, admin and finance creating a well-rounded and capable organisation.
Serosep’s market reputation is built on understanding and servicing its customers’ needs through its product innovation, manufacturing quality and dedicated 7 day a week support. This customer-centric approach and the availability of real-time technical support seven days a week is a significant advantage. This level of support can be crucial for end-users, such as laboratories.
